ALT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.10%

Insider Buying (Last 12 Months): $864.00

Insider Selling (Last 12 Months): $0.00

Altimmune Insider Trading History Chart

Altimmune Share Price & Price History

^$6.75

▲ +0.06 (0.90%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

This student turned $1,300 into $45,000 in just 4 Months!

From Monument Traders Alliance | Ad

With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... In fact, it just detected a move happening this MONDAY.

See here to see the full details.

Altimmune Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/15/2023	David Drutz	Director	Buy	300	$2.88	$864.00	29,785
3/23/2023	David Drutz	Director	Buy	9,000	$4.27	$38,430.00	29,484
3/23/2023	Matthew Scott Harris	Insider	Buy	10,000	$4.22	$42,200.00	33,311
12/22/2022	Wayne Pisano	Director	Sell	20,000	$15.01	$300,200.00	8,498
8/12/2022	Vipin K Garg	CEO	Sell	15,000	$15.06	$225,900.00	259,804
7/5/2022	M Scot Roberts	Insider	Sell	10,182	$12.00	$122,184.00	8,305
7/1/2022	M Scot Roberts	Insider	Sell	26,982	$12.00	$323,784.00	17,700
6/29/2022	M Scot Roberts	Insider	Sell	5,462	$12.00	$65,544.00	17,700
6/27/2022	Diane Jorkasky	Director	Sell	17,610	$11.75	$206,917.50
6/27/2022	M Scot Roberts	Insider	Sell	37,352	$12.00	$448,224.00	17,700
6/15/2022	David Drutz	Director	Buy	1,000	$8.00	$8,000.00	20,012
5/24/2022	David Drutz	Director	Buy	1,200	$4.50	$5,400.00	19,012
2/28/2022	Matthew Scott Harris	Insider	Sell	30,000	$7.52	$225,600.00

J.P. Morgan’s DIRE Warning

From Behind the Markets | Ad

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

SEC Filings (Institutional Ownership Changes) for Altimmune (NASDAQ:ALT)

78.05% of Altimmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Altimmune Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Bank of New York Mellon Corp	243,808	$1.62M	0.0%	+28.6%	0.344%
7/22/2024	Horizon Wealth Management LLC	10,000	$66K	0.0%	N/A	0.014%
7/20/2024	Hennion & Walsh Asset Management Inc.	129,276	$0.86M	0.0%	N/A	0.182%
7/12/2024	SG Americas Securities LLC	254,571	$1.69M	0.0%	+542.8%	0.359%
5/24/2024	Cetera Advisors LLC	60,800	$0.62M	0.0%	+19.6%	0.086%
5/24/2024	Farallon Capital Management LLC	470,000	$4.79M	0.0%	+1,282.4%	0.663%
5/17/2024	Tidal Investments LLC	13,827	$0.14M	0.0%	N/A	0.020%
5/16/2024	California State Teachers Retirement System	53,730	$0.55M	0.0%	+517.7%	0.076%
5/16/2024	Knoll Capital Management LLC	567,219	$5.77M	3.6%	+183.6%	0.800%
5/15/2024	Price T Rowe Associates Inc. MD	15,238	$0.16M	0.0%	+13.6%	0.021%
5/14/2024	TFO Wealth Partners LLC	5,020	$51K	0.0%	N/A	0.007%
5/14/2024	CANADA LIFE ASSURANCE Co	4,354	$44K	0.0%	N/A	0.006%
5/10/2024	Vanguard Group Inc.	3,128,728	$31.85M	0.0%	-12.4%	4.413%
5/8/2024	Entropy Technologies LP	34,527	$0.35M	0.0%	N/A	0.049%
5/7/2024	Sei Investments Co.	47,079	$0.48M	0.0%	N/A	0.066%
5/7/2024	Bernardo Wealth Planning LLC	11,913	$0.12M	0.0%	N/A	0.017%
5/7/2024	Swiss National Bank	106,000	$1.08M	0.0%	N/A	0.150%
5/7/2024	SG Americas Securities LLC	39,603	$0.40M	0.0%	+68.3%	0.056%
5/3/2024	GSA Capital Partners LLP	51,153	$0.52M	0.0%	-75.6%	0.072%
5/1/2024	BNP Paribas Financial Markets	32,425	$0.33M	0.0%	+154.0%	0.046%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	26,666	$0.27M	0.0%	N/A	0.038%
5/1/2024	Sequoia Financial Advisors LLC	10,155	$0.10M	0.0%	N/A	0.014%
4/30/2024	North Star Investment Management Corp.	3,000	$31K	0.0%	N/A	0.004%
4/30/2024	Commonwealth Equity Services LLC	79,945	$0.81M	0.0%	+31.5%	0.113%
4/23/2024	Gerber LLC	281,778	$2.87M	2.4%	+10.2%	0.397%
4/23/2024	Wealth Effects LLC	14,700	$0.15M	0.1%	N/A	0.021%
4/10/2024	EWG Elevate Inc.	10,000	$0.10M	0.0%	-33.3%	0.014%
3/5/2024	Gerber LLC	255,778	$2.88M	2.6%	N/A	0.476%
2/14/2024	Brown Wealth Management LLC	75,000	$0.84M	0.4%	N/A	0.140%
2/14/2024	Pennant Investors LP	109,800	$1.24M	0.3%	N/A	0.204%
2/14/2024	Lighthouse Investment Partners LLC	399,357	$4.49M	0.2%	N/A	0.743%
2/14/2024	Sectoral Asset Management Inc.	170,800	$1.92M	0.8%	N/A	0.318%
2/13/2024	Timelo Investment Management Inc.	809,095	$9.10M	7.9%	+2,597.0%	1.506%
2/8/2024	Independent Advisor Alliance	10,000	$0.11M	0.0%	N/A	0.019%
2/7/2024	Jump Financial LLC	10,660	$0.12M	0.0%	N/A	0.020%
2/6/2024	Deuterium Capital Management LLC	10,000	$0.11M	0.4%	N/A	0.019%
2/5/2024	Russell Investments Group Ltd.	4,303	$48K	0.0%	+1,150.9%	0.008%
2/1/2024	New York State Common Retirement Fund	21,396	$0.24M	0.0%	-13.1%	0.040%
1/30/2024	Vontobel Holding Ltd.	20,800	$0.23M	0.0%	N/A	0.039%
1/25/2024	Vahanian & Associates Financial Planning Inc.	10,000	$0.11M	0.4%	-27.3%	0.019%
1/24/2024	DekaBank Deutsche Girozentrale	45,000	$0.53M	0.0%	N/A	0.084%
1/22/2024	Horizon Wealth Management LLC	10,000	$0.11M	0.0%	N/A	0.019%
1/17/2024	Connective Portfolio Management LLC	16,000	$0.18M	0.4%	N/A	0.030%
1/12/2024	FNY Investment Advisers LLC	3,171	$35K	0.0%	N/A	0.006%
1/12/2024	SG Americas Securities LLC	23,525	$0.27M	0.0%	-45.4%	0.044%
1/10/2024	Allied Investment Advisors LLC	24,350	$0.27M	0.1%	N/A	0.045%
1/9/2024	EWG Elevate Inc.	15,000	$0.17M	0.1%	+50.0%	0.028%
11/22/2023	Graham Capital Management L.P.	94,105	$0.25M	0.0%	-34.4%	0.175%
11/15/2023	WealthPlan Investment Management LLC	11,931	$31K	0.0%	N/A	0.022%
11/15/2023	GSA Capital Partners LLP	445,868	$1.16M	0.1%	+153.1%	0.830%
11/15/2023	Laurion Capital Management LP	809,685	$2.11M	0.0%	-56.0%	1.507%
11/15/2023	Ardsley Advisory Partners LP	992,050	$2.58M	0.6%	-4.8%	1.846%
11/14/2023	Corton Capital Inc.	10,202	$27K	0.0%	-75.2%	0.019%
11/14/2023	Avidity Partners Management LP	1,159,900	$3.02M	0.1%	-1.2%	2.159%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	34,052	$89K	0.0%	-79.5%	0.063%
11/13/2023	Dark Forest Capital Management LP	230,353	$0.60M	0.0%	+13.4%	0.429%
11/9/2023	WealthPlan Investment Management LLC	11,931	$31K	0.0%	N/A	0.023%
11/7/2023	Quantbot Technologies LP	15,300	$40K	0.0%	N/A	0.029%
11/7/2023	Barclays PLC	180,409	$0.47M	0.0%	+62.0%	0.342%
10/25/2023	Miracle Mile Advisors LLC	17,000	$44K	0.0%	N/A	0.032%
10/24/2023	Bank of New York Mellon Corp	178,907	$0.47M	0.0%	-7.8%	0.340%
10/18/2023	Keudell Morrison Wealth Management	14,000	$36K	0.0%	N/A	0.027%
10/13/2023	SG Americas Securities LLC	43,086	$0.11M	0.0%	+63.1%	0.082%
10/13/2023	Brave Asset Management Inc.	15,000	$39K	0.0%	N/A	0.028%
10/10/2023	EWG Elevate Inc.	10,000	$26K	0.0%	-61.5%	0.019%
9/21/2023	Barclays PLC	111,395	$0.39M	0.0%	-50.9%	0.211%
8/15/2023	Sphera Funds Management LTD.	500,000	$1.77M	0.3%	+66.7%	1.014%
8/14/2023	Graham Capital Management L.P.	143,429	$0.51M	0.0%	N/A	0.291%
8/4/2023	American International Group Inc.	23,791	$84K	0.0%	N/A	0.048%
8/3/2023	Barclays PLC	111,395	$0.39M	0.0%	-50.9%	0.226%
7/24/2023	Allspring Global Investments Holdings LLC	19,842	$70K	0.0%	N/A	0.040%
7/18/2023	Allspring Global Investments Holdings LLC	19,842	$70K	0.0%	N/A	0.040%
7/12/2023	EWG Elevate Inc.	26,000	$92K	0.0%	N/A	0.053%
7/10/2023	SG Americas Securities LLC	26,425	$93K	0.0%	+73.8%	0.054%
5/22/2023	Arete Wealth Advisors LLC	28,427	$0.32M	0.0%	N/A	0.058%
5/16/2023	Ardsley Advisory Partners LP	1,447,250	$6.11M	1.3%	+105.4%	2.937%
5/12/2023	Sectoral Asset Management Inc.	479,100	$2.02M	0.4%	+39.9%	0.972%
5/12/2023	Boulder Hill Capital Management LP	11,800	$50K	0.0%	N/A	0.024%
5/12/2023	Dark Forest Capital Management LP	43,935	$0.19M	0.0%	N/A	0.089%
5/12/2023	SeaCrest Wealth Management LLC	27,353	$0.12M	0.0%	+16.2%	0.056%
5/12/2023	Profund Advisors LLC	93,919	$0.40M	0.0%	N/A	0.191%
5/12/2023	Platinum Investment Management Ltd.	95,081	$0.40M	0.0%	-19.9%	0.193%
5/10/2023	Beirne Wealth Consulting Services LLC	249,420	$1.05M	0.7%	+5.2%	0.506%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	78,557	$0.33M	0.0%	N/A	0.159%
5/10/2023	Tekla Capital Management LLC	75,000	$0.32M	0.0%	N/A	0.152%
5/9/2023	Tower Research Capital LLC TRC	20,093	$85K	0.0%	-31.4%	0.041%
5/9/2023	Y Intercept Hong Kong Ltd	32,695	$0.14M	0.0%	N/A	0.066%
5/5/2023	Pitcairn Co.	16,261	$69K	0.0%	N/A	0.033%
5/4/2023	Barclays PLC	226,861	$0.96M	0.0%	-37.2%	0.460%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	20,791	$88K	0.0%	N/A	0.042%
5/3/2023	Jump Financial LLC	288,700	$1.22M	0.1%	N/A	0.586%
5/1/2023	Arete Wealth Advisors LLC	28,427	$322.36B	0.0%	N/A	0.058%
4/28/2023	SG Americas Securities LLC	15,202	$64K	0.0%	-36.3%	0.031%
4/18/2023	Vahanian & Associates Financial Planning Inc.	21,430	$90K	0.2%	+25.1%	0.043%
4/18/2023	ETF Managers Group LLC	16,361	$69K	0.0%	-88.2%	0.033%
3/23/2023	ETF Managers Group LLC	138,196	$2.27M	0.1%	+855.2%	0.280%
2/15/2023	Tang Capital Management LLC	2,700,450	$44.42M	6.5%	+3.8%	5.493%
2/15/2023	Avidity Partners Management LP	3,990,000	$65.64M	1.4%	+48.7%	8.116%
2/14/2023	683 Capital Management LLC	17,178	$0.28M	0.0%	N/A	0.035%
2/13/2023	Picton Mahoney Asset Management	75,570	$1.24M	0.1%	+29.5%	0.154%

Data available starting January 2016

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Today's Range

Now: $6.75

$6.73

$7.14

50 Day Range

MA: $6.89

$5.91

$8.10

52 Week Range

Now: $6.75

$2.09

$14.84

Volume

2,170,831 shs

Average Volume

4,566,466 shs

Market Capitalization

$478.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.13

Who are the company insiders with the largest holdings of Altimmune?: Altimmune's top insider investors include:
Vipin K Garg (CEO)
Matthew Scott Harris (Insider)
David Drutz (Director)
Wayne Pisano (Director)
Learn More about top insider investors at Altimmune.
Who are the major institutional investors of Altimmune?: Altimmune's top institutional investors include:
SG Americas Securities LLC — 0.36%
Bank of New York Mellon Corp — 0.34%
Hennion & Walsh Asset Management Inc. — 0.18%
Horizon Wealth Management LLC — 0.01%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Altimmune stock.
Which institutional investors are buying Altimmune stock?: During the last quarter, ALT stock was purchased by institutional investors including:
SG Americas Securities LLC
Hennion & Walsh Asset Management Inc.
Bank of New York Mellon Corp
Horizon Wealth Management LLC
Within the last year, these company insiders have bought Altimmune stock:
Vipin K Garg (CEO)
Matthew Scott Harris (Insider)
Learn More investors buying Altimmune stock.